Similarly, in tumors, although a significant population of tumor-infiltrating T cells express Tim-3, it is not known what factors in the tumor microenvironment, along with tumor antigen, play a role in the upregulation of Tim-3 on effector and Treg cells. This evidence concerns the gene HAVCR2 and neoplasm.